For decades, almost everything we knew about slowing cognitive decline came from trials run in Finland, the United States or Western Europe. Latin America, one of the world's fastest-aging regions, sat outside the evidence base its own clinical guidelines were later written from. That gap has begun to close with LatAm-FINGERS, the first large-scale brain health clinical trial designed specifically for Latin American communities.
The study, funded by the Alzheimer's Association and published in The Lancet, followed 1,065 adults aged 60 to 77 across eleven countries in the region for two years. All had risk factors for cognitive decline, and none had developed dementia. The results were presented at the Alzheimer's Association International Conference in London.
The headline number is striking: participants in the structured program improved their overall cognitive performance roughly 55 percent more per year than those who received general health guidance alone. But the figure on its own says less than it appears to. What matters is exactly what was being compared.
The trial split participants into two groups. Both received the same underlying proposal: more physical activity, healthier eating, cognitive training, active social life, and management of vascular factors such as blood pressure. The difference was the intensity of the support around it.
The flexible intervention group received general guidance and periodic health education, with a handful of group meetings over the two years. The structured intervention group followed an intensive routine: supervised exercise sessions four days a week, personalized dietary counseling, guided cognitive training, clinical monitoring and organized social support.
Both groups improved. The structured group improved significantly more. That is the operational conclusion of the study, and it is no small matter for the region's health systems: the active ingredient was not the information, it was the scaffolding around it.
The cultural adaptation was substantive rather than cosmetic. Exercise sessions drew on regional dances such as salsa and tango instead of imported gym routines. Nutritional counseling started from the MIND diet, an eating pattern linked to brain health, but was built around foods that were available and affordable in each community rather than shopping lists a retiree in Lima, Bogota or Asuncion would struggle to find or pay for.
That methodological choice explains much of the retention: more than eight in ten participants completed the full two years, a high figure for a behavioral intervention trial of that length. Researchers also recorded no serious health problems linked to the program.
The largest gains were in memory, followed by improvements in planning and processing speed. And one finding stands out: the benefits held steady regardless of participants' age, education level, ethnicity and genetic risk for Alzheimer's disease. In other words, the program did not work only for the younger, better educated or genetically fortunate.
LatAm-FINGERS does not appear out of nowhere. It extends a line of research that began with the Finnish FINGER trial, published in 2015, and continued with the U.S. POINTER study. What this Latin American version adds is the demonstration that a model designed for a high-income Nordic country can be rebuilt for eleven different contexts, with other languages, other cuisines, other health systems and other family structures, without losing its effect.
The results are worth reading precisely, however. The study measured improvements on cognitive tests over two years, not a demonstrated reduction in dementia incidence. Those are different things. Better performance on memory and executive function is a promising indicator, but establishing that these programs actually prevent Alzheimer's requires far longer follow-up, on the order of a decade. The researchers themselves frame that as the next step.
The more uncomfortable question also remains open: cost. The structured arm, the one that produced better results, is also the expensive one. Supervision four times a week, individual counseling and sustained clinical monitoring over two years is not what most public health systems in the region currently offer their older population. If the support is the factor that makes the difference, the scientific evidence arrives with a political invoice attached.
Even so, there is a practical reading that does not depend on state budgets. Every component of the program is, individually, something the evidence already supported on its own: moving more, eating better, keeping the mind active, maintaining social ties, controlling blood pressure. What this trial shows is that combining them and sustaining them over time pays off more than applying them separately, and that consistency matters more than perfecting any single component.
Latin America has one of the fastest-growing older populations on the planet and limited installed capacity to care for dementia when it arrives. In that context, a study showing that prevention is possible and locally adaptable is not just another academic data point. It is a roadmap now sitting on the desks of the people who design health policy in the region.
Any change to the routine of an older person with risk factors should be discussed with their treating physician, particularly where hypertension, diabetes or other managed conditions are involved.
